Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

Abstract
PURPOSETo evaluate the influence of cumulative dose, dose-intensity, single-dose level, and schedule of epirubicin on the risk of developing congestive heart failure (CHF) in patients with advanced...